Glucose Containing and Glucose Free Hemodialysate in Type 2 Diabetic Patients
- Conditions
- Type 2 Diabetes MellitusEnd-Stage Kidney Disease
- Registration Number
- NCT02009514
- Lead Sponsor
- Tampere University Hospital
- Brief Summary
- The purpose of this study is to investigate differences in glycemia 
 * during the whole hemodialysis day and the whole freeday
 * during hemodialysis, during the evening and the night after hemodialysis and at the same time intervals during the freeday in an unselected type 2 diabetic patient group using both glucose-containing and glucose-free dialysate.
- Detailed Description
- Not available 
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 10
- type 2 diabetic patient
- undergoing stable intermittent thrice weekly hemodialysis for at least one month
- None
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
- Name - Time - Method - Glucose below 4.0 mmol/l - In the end of a two week period - In the end of a two-week glucose-containing and glucose-free period percentage of hypoglycemic values of continuous glucose monitoring during the whole hemodialysis day is compared to the whole freeday. Similar comparison is made between the whole glucose-containing and the whole glucose-free hemodialysis day as well as between the whole glucose-containing and the whole glucose-free freeday. 
- Secondary Outcome Measures
- Name - Time - Method - Glucose below 4.0 mmol/l during specified time intervals - In the end of a two-week period - Percentage of hypoglycemia during the specified time intervals is compared within the glucose-containing and glucose-free hemodialysis day and freeday, and between the glucose-containing and glucose-free hemodialysis day and the freeday. Lastly comparisons are made between the glucose-containing and glucose-free hemodialysis day, and between the glucose-containing and glucose-free freeday. 
